Current time in Korea 14:22 Oct 19 (Thu) Year 2017 KCS KCS Publications
KCS Publications
My Journal Log In Register
HOME > Search > Browsing(BKCS) > Archives

Bulletin of the Korean Chemical Society (BKCS)

ISSN 0253-2964(Print)
ISSN 1229-5949(Online)
Volume 32, Number 8
BKCSDE 32(8)
August 20, 2011 

Biapigenin, Candidate of an Agonist of Human Peroxisome Proliferator-Activated Receptor γ with Anticancer Activity
Jin-Kyoung Kim, Soyoung Shin, Jee-Young Lee, Sojung Lee, Eunjung Lee, Qinglong Jin, Juneyoung Lee, Eun-Rhan Woo, Dong Gun Lee, Do-Young Yoon, Yangmee Kim*
Biapigenin, PPARγ agonist, Biflavonoid, Anticancer agents
Peroxisome proliferator-activated receptors (PPARs) are a subfamily of nuclear receptors (NRs). Human peroxisome proliferator-activated receptor gamma (hPPARγ) has been implicated in the pathology of numerous diseases, including obesity, diabetes, and cancer. ELISA-based hPPARγ activation assay showed that biapigenin increased the binding between hPPARγ and steroid receptor coactivator-1 (SRC-1) by approximately 3-fold. In order to confirm that biapigenin binds to hPPARγ, fluorescence quenching experiment was performed. The results showed that biapigenin has higher binding affinity to hPPARγ at nanomolar concentrations compared to indomethacin. Biapigenin showed anticancer activity against HeLa cells. Biapigenin was noncytotoxic against HaCa T cell. All these data implied that biapigenin may be a potent agonist of hPPARγ with anticancer activity. We will further investigate its anticancer effects against human cervical cancer.
2717 - 2721
Full Text